Ulcerative Colitis Clinical Trials in New York

Showing 401-420 of 884 trials

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

NCT00841789

The purpose of this study is to determine whether Etanercept (Enbrel) when used in conjunction with IVIG and aspirin, improves treatment response to IVIG in patients with Kawasaki Disease. Funding Source- FDA/OOPD

Mucocutaneous Lymph Node SyndromeKawasaki Disease

Michael Portman205 participantsStarted Mar 2009

New Hyde Park, New York, United States • New York, New York, United States • The Bronx, New York, United States +5 more locations

COMPLETEDPhase 1< 1 mile

A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia

NCT04043104

Open-label, non-randomized, dose escalation trial of AAV2hAQP1 administered via Stensen's duct to a single or both parotid glands in subjects with radiation-induced xerostomia The objectives are to evaluate the safety and identify either a maximum tolerated dose or a maximum feasible dose of a single dose of AAV2hAQP1 infused into one or both parotid glands: To evaluate subject improvement of xerostomia symptoms, to evaluate the increase in parotid gland salivary output after treatment with AAV2hAQP1, to evaluate additional efficacy outcomes.

Radiation-Induced Parotid Gland HypofunctionXerostomia Due to RadiotherapyHead and Neck Cancer

MeiraGTx UK II Ltd24 participantsStarted Jun 2019

Stanford, California, United States • Louisville, Kentucky, United States • Boston, Massachusetts, United States +3 more locations

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia

Ulcerative Colitis Trials in Other Cities

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Smoking Cessation Pilot for People Living With HIV (PLWH)

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis

A Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma

Sucralose and Lactisole Additions to OGTT in Humans

Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study

Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

Other Conditions in New York